1 mg\u00a0rasagiline\u00a0tablets\u00a0<\/p>\n\n\n\n
AZILECT contains the active substance rasagiline and is used to treat Parkinson’s disease in adults. It can be used with or without levodopa (another medicine to treat Parkinson’s disease ).
<\/p>\n\n\n\n
In Parkinson’s disease, there is a lack of cells that produce dopamine in the brain. Dopamine is a substance in the brain involved in movement control. AZILECT helps increase and maintain dopamine levels in the brain.
<\/p>\n\n\n\n
Do not take the<\/strong> following medicines while taking AZILECT:<\/p>\n\n\n\n You must wait at least 14 days after stopping AZILECT treatment before starting treatment with an MAOI or pethidine.<\/p>\n\n\n\n Talk to your doctor before taking AZILECT<\/strong><\/p>\n\n\n\n Tell your doctor if you or your family\/caregiver notices that you are developing an unusual behavior where you can not resist impulses urges or temptations to engage in certain activities that may harm yourself or others. This behavior is called impulse control disorder. In patients taking AZILECT and \/ or other medicines for Parkinson’s disease, obsessive-compulsive behavior, obsessive-compulsive disorder, gambling addiction, excessive spending, impulsive behavior, and an abnormally high sex drive or an increase in sexual thoughts or feelings have been observed. Your doctor may need to adjust your dose or stop treatment (see section 4). AZILECT can cause drowsiness and cause you to suddenly fall asleep in connection with everyday activities during the day. This is especially true if you are also taking other dopaminergic medicines (used to treat Parkinson’s disease ). For further information, see section Driving and using machines.<\/p>\n\n\n\n It is not relevant to use AZILECT in children and adolescents. AZILECT is therefore not recommended for use under 18 years of age.<\/p>\n\n\n\n Tell your doctor or pharmacist if you are taking, have recently taken or might take any other medicines. It is especially important that you tell your doctor if you are taking any of the following medicines:<\/strong><\/p>\n\n\n\n The use of AZILECT in combination with antidepressants containing fluoxetine or fluvoxamine should be avoided. If you start treatment with AZILECT, you should wait at least five weeks after stopping treatment with fluoxetine. If you start treatment with fluoxetine or fluvoxamine, you should wait at least 14 days after stopping AZILECT treatment. Tell your doctor or pharmacist if you smoke or plan to quit smoking. Smoking can reduce the amount of AZILECT in the blood.<\/p>\n\n\n\n If you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby, ask your doctor or pharmacist for advice before taking this medicine. As it is not known how AZILECT affects the pregnancy and the unborn baby, you should avoid taking AZILECT if you are pregnant.<\/p>\n\n\n\n Consult a physician before driving or using machines, as both Parkinson’s disease itself and treatment with AZILECT may affect your ability to do so. AZILECT can make you feel dizzy and drowsy. It can also cause sudden sleep attacks.<\/p>\n\n\n\n This may be worse if you are taking other medicines to treat the symptoms of Parkinson’s disease, if you are taking medicines that may cause drowsiness or if you drink alcohol while taking AZILECT. If you have experienced drowsiness ( somnolence) and\/or sudden sleep attacks before or in connection with taking AZILECT, do not drive or use machines (see section 2). Always take this medicine exactly as your doctor or pharmacist has told you. Ask your doctor or pharmacist if you are unsure. The recommended dose of AZILECT is 1 tablet of 1 mg daily, taken orally. AZILECT can be taken with or without food.<\/p>\n\n\n\n If you think you have taken too many AZILECT tablets, contact your doctor or pharmacist immediately. Bring the carton\/blister pack or jar of AZILECT to see your doctor or pharmacist. Reported symptoms due to overdose of AZILECT include mild euphoric mood (a mild form of mania), extremely high blood pressure, and serotonergic syndrome (see section 4).<\/p>\n\n\n\n Do not take a double dose to make up for a forgotten dose. Take the next dose as usual when it’s time to take it.<\/p>\n\n\n\n Do not stop taking AZIELCT without first talking to your doctor. If you have any further questions on the use of this product, ask your doctor or pharmacist.<\/p>\n\n\n\n Like all medicines, this medicine can cause side effects, although not everybody gets them. Contact a doctor immediately<\/strong> if you notice any of the following symptoms. You may need urgent medical advice or treatment:<\/p>\n\n\n\n Other side effects ar<\/strong> Very common (may affect more than 1 user in 10)<\/em><\/p>\n\n\n\n Common (may affect up to 1 in 10 people)<\/em><\/p>\n\n\n\n Uncommon (may affect up to 1 in 100 people)<\/em><\/p>\n\n\n\n Has been reported (occurs in an unknown number of users)<\/em><\/p>\n\n\n\n Reporting of side effects<\/em><\/p>\n\n\n\n If you get any side effects, talk to your doctor, pharmacist, or nurse. This includes any possible side effects not listed in this leaflet. You can also report side effects directly to the Medical Products Agency, www.lakemedelsverket.se. By reporting side effects, you can help increase drug safety information. <\/p>\n\n\n\n Keep this medicine out of the sight and reach of children. Do not use this medicine after the expiry date which is stated on the carton, jar, or blister after EXP. date \/ EXP. The expiration date is the last day of the specified month. Do not store above 25 \u00b0 C. Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. These measures will help to protect the environment.<\/p>\n\n\n\n AZILECT tablets are white to off-white, round, flat tablets with a beveled edge, marked with \u201cGIL\u201d and \u201c1\u201d on one side and smooth on the other side. The tablets are available in blister packs of 7, 10, 28, 30, 100, and 112 tablets or in a can containing 30 tablets. Not all pack sizes may be marketed.<\/p>\n\n\n\n Holders of marketing authorization:<\/strong><\/p>\n\n\n\n Teva BV<\/p>\n\n\n\n Swensen 5<\/p>\n\n\n\n 2031 GA Haarlem<\/p>\n\n\n\n Netherlands Manufacturer:<\/strong><\/p>\n\n\n\n Teva Pharmaceuticals Europe BV<\/p>\n\n\n\n Swensen 5<\/p>\n\n\n\n 2031 GA Haarlem<\/p>\n\n\n\n Netherlands Pliva Croatia Ltd.<\/p>\n\n\n\n Prilaz baruna Filipovica 25<\/p>\n\n\n\n 10000 Zagreb<\/p>\n\n\n\n Croatia Teva Operations Poland Sp.z oo<\/p>\n\n\n\n ul. Mogilska 80,<\/p>\n\n\n\n 31-546 Krakow, Poland<\/p>\n\n\n\n Poland Contact the representative of the marketing authorization holder to find out more about this medicine:<\/p>\n\n\n\n AZILECT contains the active substance rasagiline and is used to treat Parkinson’s disease in adults. It can be used with or without levodopa (another medicine to treat Parkinson’s disease ).<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"cybocfi_hide_featured_image":"","footnotes":""},"categories":[2201,2200],"tags":[9487,9490,9482,9484,9491,9486,9489,9488,9483,9485],"class_list":["post-5800","post","type-post","status-publish","format-standard","hentry","category-a","category-medicines","tag-azilect","tag-azilect-tablet","tag-rasagiline","tag-rasagiline-tablet","tag-side-effects-of-azilect","tag-side-effects-of-rasagiline","tag-what-azilect-is-used-for","tag-what-is-azilect","tag-what-is-rasagiline","tag-what-rasagiline-is-used-for"],"_links":{"self":[{"href":"https:\/\/zeepedia.com\/medical\/wp-json\/wp\/v2\/posts\/5800","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/zeepedia.com\/medical\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/zeepedia.com\/medical\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/zeepedia.com\/medical\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/zeepedia.com\/medical\/wp-json\/wp\/v2\/comments?post=5800"}],"version-history":[{"count":5,"href":"https:\/\/zeepedia.com\/medical\/wp-json\/wp\/v2\/posts\/5800\/revisions"}],"predecessor-version":[{"id":12242,"href":"https:\/\/zeepedia.com\/medical\/wp-json\/wp\/v2\/posts\/5800\/revisions\/12242"}],"wp:attachment":[{"href":"https:\/\/zeepedia.com\/medical\/wp-json\/wp\/v2\/media?parent=5800"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/zeepedia.com\/medical\/wp-json\/wp\/v2\/categories?post=5800"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/zeepedia.com\/medical\/wp-json\/wp\/v2\/tags?post=5800"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}Warnings and cautions<\/h2>\n\n\n\n
<\/li><\/ul>\n\n\n\n
<\/p>\n\n\n\nChildren and young people<\/h2>\n\n\n\n
Other medicines and AZILECT<\/h2>\n\n\n\n
<\/p>\n\n\n\n
<\/li><\/ul>\n\n\n\n
<\/p>\n\n\n\nPregnancy, breastfeeding, and fertility<\/h2>\n\n\n\n
<\/p>\n\n\n\nDriving and using machines<\/h2>\n\n\n\n
<\/p>\n\n\n\n3. How to take AZILECT<\/h2>\n\n\n\n
<\/p>\n\n\n\nIf you take more AZILECT than you should<\/h2>\n\n\n\n
<\/p>\n\n\n\nIf you forget to take AZILECT<\/h2>\n\n\n\n
If you stop taking AZILECT<\/h2>\n\n\n\n
<\/p>\n\n\n\n4. Possible side effects<\/h2>\n\n\n\n
<\/p>\n\n\n\n
<\/li><\/ul>\n\n\n\n
<\/p>\n\n\n\n
<\/li><\/ul>\n\n\n\n
<\/li><\/ul>\n\n\n\n
<\/li><\/ul>\n\n\n\n5. How to store AZILECT<\/h2>\n\n\n\n
<\/p>\n\n\n\n
<\/p>\n\n\n\n
<\/p>\n\n\n\n6. Contents of the packaging and other information<\/h2>\n\n\n\n
Content declaration<\/h2>\n\n\n\n
What the medicine looks like and the contents of the pack<\/h2>\n\n\n\n
<\/p>\n\n\n\n
<\/p>\n\n\n\nMarketing Authorization Holder and Manufacturer<\/h2>\n\n\n\n
<\/p>\n\n\n\n
<\/p>\n\n\n\n
<\/p>\n\n\n\n
<\/p>\n\n\n\nBelgium \/ Belgique \/ Belgien<\/strong>Teva Pharma Belgium NV \/ SA \/ AGTel: +32 3 820 73 73<\/td> Lithuania<\/strong>UAB “Sicor Biotech”Tel: +370 5 266 0203<\/td><\/tr> Bulgaria<\/strong>Teva Pharmaceuticals Bulgaria \u0415\u041e\u041e\u0414Tel: +359 2 489 95 82<\/td> Luxembourg \/ Luxemburg<\/strong>Teva Pharma Belgium NV \/ SA \/ AG, Belgium \/ BelgiumTel: +32 3 820 73 73<\/td><\/tr> Czech Republic<\/strong>Teva Pharmaceuticals CR, sroTel: +420 251 007 111<\/td> Hungary<\/strong>Teva Gy\u00f3gyszergy\u00e1r Zrt.Tel .: +36 1 288 6400<\/td><\/tr> Denmark<\/strong>Teva Denmark A \/ STel: +45 4498 5511<\/td> Malta<\/strong>Teva Pharmaceuticals IrelandL-IrelandTel: +353 51 321 740<\/td><\/tr> Germany<\/strong>Teva GmbHTel: +800 53 23 66 48<\/td> The Netherlands<\/strong>Teva Nederland BVTel: +31 (0) 800 0228400<\/td><\/tr> Eesti<\/strong>Teva Eesti esindusUAB Sicor Biotech Eesti subsidiaryTel: +372 6610801<\/td> Norway<\/strong>Teva Norway ASTel: +47 66775590<\/td><\/tr> Greece<\/strong>Teva \u0391\u03bb\u03bb\u03ac\u03c2 \u0391.\u0395.:\u0397\u03bb: +30 210 72 79 099<\/td> Austria<\/strong>ratiopharm Arzneimittel Vertriebs-GmbHTel .: +43 (0) 1 97007<\/td><\/tr> Spain<\/strong>Teva Pharma, SLUTel: +34 91 387 32 80<\/td> Poland<\/strong>Teva Pharmaceuticals Polska Sp. z ooTel .: +48 22 345 93 00<\/td><\/tr> France<\/strong> Teva HealthTel: +33 1 55 91 7800<\/td> Portugal<\/strong>Teva Pharma – ProductsPharmacists LdaTel: +351 21 476 75 50<\/td><\/tr> Croatia<\/strong>Pliva Hrvatska dooTel .: + 385 1 37 20 000<\/td> Romania<\/strong>Teva Pharmaceuticals SRLTel: +4021 230 65 24<\/td><\/tr> Ireland<\/strong>Teva Pharmaceuticals IrelandTel: +353 51 321 740<\/td> Slovenia<\/strong>Pliva Ljubljana dooTel: +386 1 58 90 390<\/td><\/tr> Iceland<\/strong>Vistor hf.Phone: +354 535 7000<\/td> Slovak Republic<\/strong>TEVA Pharmaceuticals Slovakia sroTel: +421 2 572 679 11<\/td><\/tr> Italy<\/strong>Teva Italia SrlTel: +39 028917981<\/td> Finland \/ Finland<\/strong>ratiopharm OyPuh \/ Tel: +358 20 180 5900<\/td><\/tr> \u039a\u03cd\u03c0\u03c1\u03bf\u03c2<\/strong>Teva \u0391\u03bb\u03bb\u03ac\u03c2 \u0391.\u0395., .\u03bb\u03bb\u03ac\u03b4\u03b1:\u0397\u03bb: +30 210 72 79 099<\/td> <\/td><\/tr> Latvia<\/strong>UAB “Sicor Biotech” branch of LatviaTel: +371 67 323 666<\/td> United Kingdom<\/strong>Teva UK LimitedTel: +44 (0) 1977 628500<\/td><\/tr><\/tbody><\/table><\/figure>\n","protected":false},"excerpt":{"rendered":"